Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell division cycle associated 4 pseudogene 2 (CDCA4P2) is a processed pseudogene—a non-functional segment of genomic DNA that arises as a retrocopy (reverse transposed copy) of the functional CDCA4 gene. Pseudogenes like CDCA4P2 are widely distributed in the genome and typically lack protein-coding capacity due to disruptive mutations, absence of regulatory elements, or truncation. They do not give rise to functional proteins and generally do not play a direct role in physiological or pathological processes. CDCA4P2 is annotated in gene databases such as NCBI Gene (100129348), Ensembl (ENSG00000224466), and HGNC (49771), but has no documented function, therapeutic relevance, or disease association. Its only biological context is as a genomic fossil derived from the parent CDCA4 gene through the process of retrotransposition.
None.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell division cycle associated 4 pseudogene 2 (CDCA4P2).